Corpus Intelligence IC Memo — MONROE HEALTH SERVICES INC. 2026-04-26 07:43 UTC
IC Memo — MONROE HEALTH SERVICES INC.
Investment Committee Memorandum | MS | 94 beds | Grade C | EBITDA uplift $3.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MONROE HEALTH SERVICES INC.

CCN 250025 | MONROE, MS | 94 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MONROE HEALTH SERVICES INC. is a 94-bed suburban community hospital in MONROE, MS with $46.0M in net patient revenue and a 6.2% operating margin. The hospital serves a payer mix of 36.4% Medicare, 27.2% Medicaid, and 36.5% commercial.

Thesis: Turnaround. Our ML models identify $3.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.2% to 13.6% (+736bps).

Net Revenue HCRIS$46.0M
Current EBITDA COMPUTED$2.9M
Operating Margin COMPUTED6.2%
Occupancy HCRIS29.8%
Revenue / Bed COMPUTED$489K
Net-to-Gross HCRIS20.4%
Distress Probability ML58.8%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
33
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of 6.2% places it above the state median. Among 33 size-comparable peers (47-188 beds), the median margin is -4.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (47-188), prioritizing same-state peers. 33 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MONROE HEALTH SERVICES INC. (Target)MS94$46.0M6.2%
BAPTIST MEM HOSPITAL GOLDEN TRMS154$221.1M6.9%
MAGNOLIA HOSPITALMS158$161.6M-4.7%
MERIT HEALTH WESLEYMS121$140.9M1.3%
RIVER OAKS HOSPITALMS158$124.1M7.0%
SOUTHWEST MS REGIONAL MED CENTMS97$123.1M-16.0%
BAPTIST MEM HOSPITAL UNION COUMS83$117.9M3.7%
DELTA HEALTH-THE MEDICAL CENTEMS101$112.1M-26.9%
MERIT HEALTH RIVER REGIONMS155$106.8M1.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$965K+210bp18mo
Cost to Collect4.5%2.5%$919K+200bp12mo
Denial Rate Reduction12.0%6.5%$910K+198bp12mo
A/R Days Reduction5200.0%3800.0%$559K+122bp9mo
Clean Claim Rate88.0%96.0%$29K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$965K
Cost to Collect
$919K
Denial Rate Reduction
$910K
A/R Days Reduction
$559K
Clean Claim Rate
$29K
Total EBITDA Uplift$3.4M
Current EBITDA$2.9M
+ RCM Uplift+$3.4M
Pro Forma EBITDA$6.2M
Current Margin6.2%
Pro Forma Margin13.6%
WC Released (1x)$1.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$4.4M$52.6M11.99x64.4%
Base (11x exit)10.0x11.0x$4.4M$59.3M13.52x68.3%
Bull Case9.0x11.0x$4.0M$71.9M18.21x78.7%
Bull (12x exit)9.0x12.0x$4.0M$79.6M20.16x82.3%
Bear Case11.0x10.0x$4.8M$34.3M7.11x48.0%
Bear (11x exit)11.0x11.0x$4.8M$39.3M8.14x52.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumElevated Medicaid exposure (27.2%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
MediumLow occupancyAt 29.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 58.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 33 hospitals with 47-188 beds
  • Same-state prioritization (n=34)
  • Comp margins: P25=-19.0% / P50=-4.7% / P75=1.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.